ETrade Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $522K | Sell |
4,565
-373
| -8% | -$42.7K | 0.01% | 546 |
|
|
2020
Q2 | $555K | Sell |
4,938
-204
| -4% | -$22.9K | 0.01% | 512 |
|
|
2020
Q1 | $462K | Sell |
5,142
-547
| -10% | -$49.1K | 0.01% | 489 |
|
|
2019
Q4 | $615K | Buy |
+5,689
| New | +$615K | 0.01% | 499 |
|
|
2019
Q3 | – | Sell |
-13,178
| Closed | -$1.73M | – | 854 |
|
|
2019
Q2 | $1.73M | Sell |
13,178
-2,013
| -13% | -$264K | 0.05% | 235 |
|
|
2019
Q1 | $2.05M | Buy |
15,191
+1,237
| +9% | +$167K | 0.06% | 199 |
|
|
2018
Q4 | $1.36M | Sell |
13,954
-2,002
| -13% | -$195K | 0.04% | 222 |
|
|
2018
Q3 | $2.22M | Buy |
15,956
+2,341
| +17% | +$325K | 0.06% | 181 |
|
|
2018
Q2 | $1.69M | Sell |
13,615
-172
| -1% | -$21.4K | 0.05% | 212 |
|
|
2018
Q1 | $1.54M | Buy |
13,787
+51
| +0.4% | +$5.69K | 0.05% | 223 |
|
|
2017
Q4 | $1.64M | Buy |
13,736
+12,235
| +815% | +$1.46M | 0.05% | 219 |
|
|
2017
Q3 | $210K | Buy |
+1,501
| New | +$210K | 0.01% | 664 |
|
|
2017
Q2 | – | Sell |
-2,800
| Closed | -$339K | – | 733 |
|
|
2017
Q1 | $339K | Buy |
2,800
+876
| +46% | +$106K | 0.01% | 501 |
|
|
2016
Q4 | $235K | Buy |
+1,924
| New | +$235K | 0.01% | 529 |
|
|
2014
Q2 | – | Sell |
-280
| Closed | -$43K | – | 733 |
|
|
2014
Q1 | $43K | Sell |
280
-51
| -15% | -$7.83K | ﹤0.01% | 580 |
|
|
2013
Q4 | $44K | Sell |
331
-16
| -5% | -$2.13K | ﹤0.01% | 481 |
|
|
2013
Q3 | $40K | Buy |
347
+31
| +10% | +$3.57K | ﹤0.01% | 461 |
|
|
2013
Q2 | $29K | Buy |
+316
| New | +$29K | ﹤0.01% | 452 |
|